Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00025688. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase II Trial of Weekly Taxol (Paclitaxel) Versus Weekly Taxol Plus Paraplatin (Carboplatin) as First-Line Chemotherapy in Patients Age 65 Years or Older With Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if paclitaxel is more effective with or without carboplatin in treating stage IV breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of paclitaxel with or without carboplatin in treating women who have stage IV breast cancer.
Study identification
- NCT ID
- NCT00025688
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 24, 2008
Started 2001
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group | Springdale | Arkansas | 72764 | — |
| Monterey Bay Oncology | Monterey | California | 93940 | — |
| Wilshire Oncology Medical Group, Inc. | Pomona | California | 91767-3021 | — |
| University of California Davis Cancer Center | Sacramento | California | 95817 | — |
| New Britain General Hospital | New Britain | Connecticut | 06050 | — |
| Center for Hematology and Oncology | Boca Raton | Florida | 33486 | — |
| Cancer Research Network, Inc. | Hollywood | Florida | 33020 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| MacNeal Cancer Center | Berwyn | Illinois | 60402 | — |
| Oncology Specialists, SC | Park Ridge | Illinois | 60068 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074 | — |
| Maryland Hematology/Oncology Associates | Baltimore | Maryland | 21236 | — |
| St. John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| St. Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Finger Lakes Community Cancer Center | Clifton Springs | New York | 14432 | — |
| Clinical Hematology & Oncology Service, Inc. | Akron | Ohio | 44302 | — |
| Scranton Hematology-Oncology | Scranton | Pennsylvania | 18510 | — |
| East Tennessee Oncology/Hematology, P.C. | Knoxville | Tennessee | 37920 | — |
| West Clinic | Memphis | Tennessee | 38120 | — |
| Texas Cancer Care | Fort Worth | Texas | 76104 | — |
| Oncology Consultants | Houston | Texas | 77024 | — |
| Scott and White Clinic | Temple | Texas | 76508 | — |
| Northern Virginia Oncology Group, P.C. | Fairfax | Virginia | 22031 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| Dean Medical Center | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00025688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2008 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.